Diagnosis and treatment of basaloid squamous cell carcinoma of the esophagus.
- Author:
Jian-Xiang CHEN
1
;
Qiu TANG
;
Hui-Neng ZHU
;
Yuan-Da ZHENG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Antineoplastic Agents; therapeutic use; Carcinoma, Basosquamous; diagnosis; therapy; Carcinoma, Squamous Cell; diagnosis; Cisplatin; administration & dosage; Combined Modality Therapy; Diagnosis, Differential; Esophageal Neoplasms; diagnosis; therapy; Esophagectomy; methods; Esophagus; pathology; surgery; Female; Fluorouracil; administration & dosage; Follow-Up Studies; Humans; Liver Neoplasms; secondary; Lung Neoplasms; secondary; Male; Middle Aged; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate
- From: Chinese Journal of Oncology 2008;30(5):392-395
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the histopathological features of basaloid squamous cell carcinoma of the esophagus, and to explore the ways of its diagnosis, differential diagnosis and treatment.
METHODSThe clinical data and pathological features of 23 cases of esophageal basaloid squamous cell carcinoma were reviewed and analyzed retrospectively.
RESULTSThe tumors were mainly located at the middle third segment of the esophagus. The 1-,2- and 3-year survival rates were 60.9%, 21.7% and 0, respectively.
CONCLUSIONThe basaloid squamous cell carcinoma of the esophagus is highly malignant with poor prognosis. Radical resection combined with radiotherapy and chemotherapy is required.
